1. Home
  2. CARA vs LSH Comparison

CARA vs LSH Comparison

Compare CARA & LSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARA
  • LSH
  • Stock Information
  • Founded
  • CARA 2004
  • LSH 2018
  • Country
  • CARA United States
  • LSH United States
  • Employees
  • CARA N/A
  • LSH N/A
  • Industry
  • CARA Biotechnology: Pharmaceutical Preparations
  • LSH
  • Sector
  • CARA Health Care
  • LSH
  • Exchange
  • CARA Nasdaq
  • LSH NYSE
  • Market Cap
  • CARA 23.1M
  • LSH 8.8M
  • IPO Year
  • CARA 2014
  • LSH 2024
  • Fundamental
  • Price
  • CARA $4.94
  • LSH $1.08
  • Analyst Decision
  • CARA Hold
  • LSH
  • Analyst Count
  • CARA 3
  • LSH 0
  • Target Price
  • CARA $12.00
  • LSH N/A
  • AVG Volume (30 Days)
  • CARA 16.0K
  • LSH 123.5K
  • Earning Date
  • CARA 03-14-2025
  • LSH 05-01-2025
  • Dividend Yield
  • CARA N/A
  • LSH N/A
  • EPS Growth
  • CARA N/A
  • LSH N/A
  • EPS
  • CARA N/A
  • LSH N/A
  • Revenue
  • CARA $8,686,000.00
  • LSH $16,927,719.00
  • Revenue This Year
  • CARA N/A
  • LSH N/A
  • Revenue Next Year
  • CARA N/A
  • LSH N/A
  • P/E Ratio
  • CARA N/A
  • LSH N/A
  • Revenue Growth
  • CARA N/A
  • LSH 2.84
  • 52 Week Low
  • CARA $2.71
  • LSH $1.06
  • 52 Week High
  • CARA $12.12
  • LSH $5.37
  • Technical
  • Relative Strength Index (RSI)
  • CARA 47.13
  • LSH N/A
  • Support Level
  • CARA $4.83
  • LSH N/A
  • Resistance Level
  • CARA $4.95
  • LSH N/A
  • Average True Range (ATR)
  • CARA 0.22
  • LSH 0.00
  • MACD
  • CARA -0.03
  • LSH 0.00
  • Stochastic Oscillator
  • CARA 51.72
  • LSH 0.00

About CARA Cara Therapeutics Inc.

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

About LSH LAKESIDE HOLDING LTD

Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.

Share on Social Networks: